Mandawa, Aira Jane .
HRN: 14-51-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/13/2026
06/20/2026
IVT
300mg
Q8
Acute Gastroenteritis
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines